Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry

被引:194
|
作者
Bi, Shuguang [1 ]
Hong, Patrick W. [2 ]
Lee, Benhur [1 ,2 ]
Baum, Linda G. [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
THIOL/DISULFIDE EXCHANGE; MEMBRANE-FUSION; EXPRESSION; RECEPTOR; GLYCOSYLATION; ORGANIZATION; ASSOCIATION; INHIBITORS; BONDS; CD4;
D O I
10.1073/pnas.1017954108
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Interaction of cell surface glycoproteins with endogenous lectins on the cell surface regulates formation and maintenance of plasma membrane domains, clusters signaling complexes, and controls the residency time of glycoproteins on the plasma membrane. Galectin-9 is a soluble, secreted lectin that binds to glycoprotein receptors to form galectin-glycoprotein lattices on the cell surface. Whereas galectin-9 binding to specific glycoprotein receptors induces death of CD4 Th1 cells, CD4 Th2 cells are resistant to galectin-9 death due to alternative glycosylation. On Th2 cells, galectin-9 binds cell surface protein disulfide isomerase (PDI), increasing retention of PDI on the cell surface and altering the redox status at the plasma membrane. Cell surface PDI regulates integrin function on platelets and also enhances susceptibility of T cells to infection with HIV. We find that galectin-9 binding to PDI on Th2 cells results in increased cell migration through extracellular matrix via beta 3 integrins, identifying a unique mechanism to regulate T-cell migration. In addition, galectin-9 binding to PDI on T cells potentiates infection with HIV. We identify a mechanism for regulating cell surface redox status via a galectin-glycoprotein lattice, to regulate distinct T-cell functions.
引用
收藏
页码:10650 / 10655
页数:6
相关论文
共 50 条
  • [21] The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy
    Yang, Riyao
    Hung, Mien-Chie
    SCIENCE CHINA-LIFE SCIENCES, 2017, 60 (10) : 1058 - 1064
  • [22] The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy
    Riyao Yang
    Mien-Chie Hung
    Science China Life Sciences, 2017, 60 : 1058 - 1064
  • [23] The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy
    Riyao Yang
    Mien-Chie Hung
    Science China(Life Sciences) , 2017, (10) : 1058 - 1064
  • [24] Prognostic impact of T-cell immunoglobulin and mucin domain-3/Galectin-9 expression in acute myeloid leukemia patients
    Fathy, Ali A. G. Asmaa
    Youssef, Nihal M. H.
    Eissa, Deena S. M.
    El-Gamal, Rasha A. R.
    Mostafa, Noha B. H.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2024, 49 (03): : 216 - 222
  • [25] Combinatorial Inhibition of Galectin-9 and CHK1 Represent a Novel Treatment Strategy for T-Cell Acute Lymphoblastic Leukemia
    Lee, Miyoung
    Filipovic, Aleksandra
    Henry, Curtis J.
    BLOOD, 2021, 138
  • [26] Leukocyte-specific protein 1 regulates T-cell migration in rheumatoid arthritis
    Hwang, Seong-Hye
    Jung, Seung-Hyun
    Lee, Saseong
    Choi, Susanna
    Yoo, Seung-Ah
    Park, Ji-Hwan
    Hwang, Daehee
    Shim, Seung Cheol
    Sabbagh, Laurent
    Kim, Ki-Jo
    Park, Sung Hwan
    Cho, Chul-Soo
    Kim, Bong-Sung
    Leng, Lin
    Montgomery, Ruth R.
    Bucala, Richard
    Chung, Yeun-Jun
    Kim, Wan-Uk
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (47) : E6535 - E6543
  • [27] Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors
    Komita, Hideo
    Koido, Shigeo
    Hayashi, Kazumi
    Kan, Shin
    Ito, Masaki
    Kamata, Yuko
    Suzuki, Masafumi
    Homma, Sadamu
    ONCOLOGY REPORTS, 2015, 34 (04) : 2099 - 2105
  • [28] A modified version of galectin-9 suppresses cell growth and induces apoptosis of human T-cell leukemia virus type I-infected T-cell lines (Retraction of vol 120, pg 2251, 2007)
    Okudaira, T.
    Hirashima, M.
    Ishikawa, C.
    Makishi, S.
    Tomita, M.
    Matsuda, T.
    Kawakami, H.
    Taira, N.
    Ohshiro, K.
    Masuda, M.
    Takasu, N.
    Mori, N.
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (11) : 2762 - 2762
  • [29] Hepatocyte Galectin-9 and T-Cell TIM-3 Signaling Protects Mouse Liver Against Ischemia-Reperfusion Injury
    Liu, Yuanxing
    Ji, Haofeng
    Zhang, Yu
    Shen, Xiu-da
    Gao, Feng
    Busuttil, Ronald W.
    Kupiec-Weglinski, Jerzy W.
    TRANSPLANTATION, 2015, 99 : 99 - 99
  • [30] Delayed ischaemic preconditioning in the presence of galectin-9 protects against renal ischaemic injury through a regulatory T-cell dependent mechanism
    Zhang, Bing-Ying
    Fang, Yi
    Jiao, Xiao-Yan
    Wu, Sheng
    Cai, Jie-Ru
    Zou, Jian-Zhou
    Ding, Xiao-Qiang
    NEPHROLOGY, 2016, 21 (10) : 828 - 834